Abbott Laboratories (NYSE:ABT) Passes the Caviar Cruise Quality Screen with Strong Growth and Profitability

Abbott Laboratories (NYSE:ABT) Passes the Caviar Cruise Quality Screen with Strong Growth and Profitability  ChartMill

Summary aggregated from ChartMill's public RSS feed. The full reporting belongs to ChartMill — please read it on their site.